Object's details: Effect of siltuximab, omalizumab, infliximab, pembrolizumab and vedolizumab on selected haematological and biochemical parameters in a pig model

Similar objects

tile.noImage
tile.noImage
tile.noImage
tile.noImage
tile.noImage
We use files, through the cookie quality improvement layer of our website.For more information, please read the document Privacy Policy